Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIT for Early Hodgkin's Disease
NCT00002987Phase 3Unknown
- Sponsor
- Medical Research Council
- Start
- Jan 1997
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of vincristine, doxorubicin, prednisolone, etoposide, cyclophosphamide in Hodgkin lymphoma (HL), sponsored by Medical Research Council. Status: unknown.
02
Drugs
vincristinedoxorubicinprednisoloneetoposidecyclophosphamide
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00002987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002987.